Cancer-associated regulation of alternative splicing

Area of Science:

• Molecular Biology
• Genetics
• Cancer Research

Background:

• Alternative splicing of pre-messenger RNA (mRNA) significantly expands the diversity of protein functions.
• Aberrant alternative splicing is a hallmark of many human cancers, contributing to tumorigenesis.

Purpose of the Study:

• To investigate the role of RNA binding proteins in cancer-associated alternative splicing events.
• To identify specific splicing regulatory factors and their mechanisms in ovarian and breast cancers.

Main Methods:

• Sequence analysis to identify RNA binding protein binding sites near alternatively spliced exons.
• High-resolution mapping of binding sites for the RNA binding protein FOX2.
• Depletion of FOX2 in cell lines to assess its impact on alternative splicing.
• Analysis of FOX2 expression and splicing patterns in human ovarian and breast cancer tissues.

Main Results:

• Approximately 50% of active alternative splicing events are altered in ovarian and breast tumors.
• FOX2 binding sites are located downstream of one-third of cancer-specific skipped exons.
• FOX2 can act as either a splicing silencer or enhancer, depending on its binding site.
• FOX2 depletion in cell lines recapitulates splicing changes observed in cancer tissues.
• FOX2 expression is downregulated in ovarian cancer, and its splicing is altered in breast cancer.

Conclusions:

• The RNA binding protein FOX2 plays a significant role in regulating alternative splicing in normal and cancerous ovarian and breast tissues.
• Reduced FOX2 expression in cancer contributes to altered splicing patterns, potentially influencing cancer cell proliferation.
• FOX2 is a key regulator whose dysregulation in cancer impacts splicing fidelity and cellular processes.